I am glad that the House has finally decided to confront what can only be described as a national embarrassment. Today we must take steps to prevent our low-income seniors from paying the highest prescription drug prices in the world. Reimportation is a valid approach. While it may slice drug profits, it costs taxpayers nothing. If we do not act to protect seniors from skyrocketing drug prices, I worry that it is because we are choosing to protect drug companies from competition on the world market. This competition with willing sellers of FDA approved drugs from abroad will ensure that our seniors get the lower prices that citizens in other countries enjoy. Opponents of this common sense solution warn of grave risks, which the evidence suggests are wildly exaggerated. There are certainly fewer risks than continuing the mass underground reimportation that takes place today. Tonight's vote is an important step in this struggle to stop the exploitation of seniors. It is, however, just a beginning. I look forward to building on this momentum for the hard task ahead.
On the recordJuly 24, 2003
Source
govinfo.govEditor's note · Context
Addressing the issue of high prescription drug prices for low-income seniors.
Share
More from Earl Blumenauer
Feb 13, 2024
I urge you to reconsider your support for this legislation and address your concerns without compromising robust enforcement.
Sep 19, 2024
I would like to start by commending the Biden-Harris administration for their leadership role in the recent extension of the WTO e-commerce moratorium.
Jun 25, 2024
I have 190 days left in Congress, so I have been spending time on issues that bring people together rather than divide them.
Feb 6, 2024
Either we continue to pursue things on a bilateral basis or take unilateral action when it comes to trade policies, or we invest in a system with other like-minded allies to address things like China's unfair trade practices.





